Malaysia-based health supplement maker DXN Holdings Bhd is set to close the first round of bids in an ongoing auction process at the end of July, people familiar with the process told DealStreetAsia.
Owners of the firm, including Southeast Asia-focused private equity firm KV Asia Capital, have appointed Morgan Stanley to advise on the sale. Bloomberg had earlier reported that a deal could value the supplement producer at as much as $1 billion, including debt.
